Study of HCD122 in Adults With Non-Hodgkin's or Hodgkin's Lymphoma Who Have Progressed After at Least Two Prior Therapies

Novartis Investigative Site, Leuven

Novartis Investigative Site, Parkville

Novartis Investigative Site, Prahran

Novartis Investigative Site, Godinne

Novartis Investigative Site, Ghent

Novartis Investigative Site, Berlin

Novartis Investigative Site, Milan

Wake Forest University Baptist Medical Center Dept. of Industry Research (2), Winston-Salem

Novartis Investigative Site, Montpellier

Novartis Investigative Site, Bologna

St. Francis Cancer Research Foundation Dept.ofSt.FrancisCancerRes.(2), Beech Grove

Novartis Investigative Site, Cologne

Novartis Investigative Site, Pisa

Northwestern University, Chicago

Novartis Investigative Site, Le Mans

Novartis Investigative Site, Paris

Novartis Investigative Site, Créteil

Novartis Investigative Site, Singapore

Dana Farber Cancer Institute SC-5, Boston

University of Texas/MD Anderson Cancer Center Dept.ofMDAndersonCancerCtr(3), Houston

Novartis Investigative Site, Toronto

Novartis Investigative Site, Montreal

Novartis Investigative Site, Lille

Novartis Investigative Site, Pierre-Benite Cédex

Novartis Investigative Site, Hong Kong

Novartis Investigative Site, Seoul

Novartis Investigative Site, Leicester

Novartis Investigative Site, London